Last Price
0.022
Today's Change
+0.002 (10.00%)
Day's Change
0.02 - 0.022
Trading Volume
310,872
Market Cap
8 Million
Shares Outstanding
43 Million
Avg Volume
0
Avg Price (50 Days)
0.00
Avg Price (200 Days)
0.00
PE Ratio
0.00
EPS
-94.13
Earnings Announcement
10-May-2024
Previous Close
0.00
Open
0.00
Day's Range
0.1864 - 0.1864
Year Range
0.1864 - 0.1864
Trading Volume
0
1 Day Change
0.00%
5 Day Change
965.14%
1 Month Change
755.05%
3 Month Change
747.27%
6 Month Change
-49.64%
Ytd Change
686.50%
1 Year Change
-89.10%
3 Year Change
-99.99%
5 Year Change
-100.00%
10 Year Change
-100.00%
Max Change
-100.00%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMBA, which is in phase I clinical trial; BX3000, an NMBA reversal agent; and Dex-IN, a proprietary intranasal formulation of dexmedetomidine. The company was incorporated in 2019 and is based in Malvern, Pennsylvania.